ArticleMolecular genetics & genomic medicine2026
Identification of the MYH6 c.804G>C Synonymous Variant Causing Exon Skipping in a Hypertrophic Cardiomyopathy Family.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHypertrophic cardiomyopathy (HCM) is a common hereditary cardiac disorder characterized by left ventricular hypertrophy, outflow tract obstruction, arrhythmias, and increased risk of sudden cardiac death.
methodsClinical phenotypes and family histories were collected from affected individuals. Whole-exome sequencing (WES) followed by Sanger sequencing identified and validated genetic variants. In silico tools predicted splicing effects, with aberrant splicing confirmed by minigene assays.
resultsThe proband, a 33-year-old male with asymmetric obstructive HCM, exhibited characteristic electrocardiographic, echocardiographic, cardiac MRI, and histopathological findings. WES revealed MYBPC3 c.787G>A and MYH6 c.804G>C (p.Leu268=) variants. Segregation analysis showed that only the synonymous MYH6 variant co-segregated with HCM in affected family members. This variant was absent from public databases (gnomAD and ClinVar) and the literature as of December 15, 2025. Although three in silico tools predicted negligible splicing impact, minigene assays in HEK293T and HeLa cells revealed partial exon 10 skipping, resulting in an in-frame deletion (p.Leu268_Asp300del) in approximately 6.8% and 4.7% of transcripts, respectively.
conclusionThe synonymous MYH6 c.804G>C variant promotes exon skipping and is associated with HCM. This study provides functional evidence supporting its potential pathogenicity and underscores the value of experimental validation in genetic diagnosis. These findings highlight the limitations of computational predictions and emphasize the importance of functional assays for evaluating synonymous variants in sarcomeric genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.